Managing Diarrhoea and Vomiting in Children

Diarrhoea and vomiting are common in young children, with rotavirus being the most common cause of gastroenteritis in the UK. According to the 2009 NICE guidelines, diarrhoea usually lasts for 5-7 days and stops within 2 weeks, while vomiting usually lasts for 1-2 days and stops within 3 days. When assessing hydration status, NICE recommends using normal, dehydrated, or shocked categories instead of the traditional mild, moderate, or severe categories.

Children younger than 1 year, especially those younger than 6 months, infants who were of low birth weight, and those who have passed six or more diarrhoeal stools in the past 24 hours or vomited three times or more in the past 24 hours are at an increased risk of dehydration. Additionally, children who have not been offered or have not been able to tolerate supplementary fluids before presentation, infants who have stopped breastfeeding during the illness, and those with signs of malnutrition are also at risk.

If clinical shock is suspected, children should be admitted for intravenous rehydration. For children without evidence of dehydration, it is recommended to continue breastfeeding and other milk feeds, encourage fluid intake, and discourage fruit juices and carbonated drinks. If dehydration is suspected, give 50 ml/kg low osmolarity oral rehydration solution (ORS) solution over 4 hours, plus ORS solution for maintenance, often and in small amounts. It is also important to continue breastfeeding and consider supplementing with usual fluids, including milk feeds or water, but not fruit juices or carbonated drinks.

In terms of diagnosis, NICE suggests doing a stool culture in certain situations, such as when septicaemia is suspected, there is blood and/or mucous in the stool, or the child is immunocompromised. A stool culture should also be considered if the child has recently been abroad, the diarrhoea has not improved by day 7, or there is uncertainty about the diagnosis of gastroenteritis. Features suggestive of hypernatraemic dehydration include jittery movements, increased muscle tone, hyperreflexia, convulsions, and drowsiness or coma.

The HPV vaccination is now given to both girls and boys aged 12-13 years old, when they enter Year 8 at school. This is the correct answer. The Hepatitis B vaccine is given at 2, 3, and 4 months of age, while the MMR vaccine is given at 1 year and 3 years, 4 months of age. The meningitis ACWY vaccine is given to school children aged 13-15 years old and to university students up to 25 years old. The tetanus, diphtheria, and polio vaccine is given at age 14.

The UK immunisation schedule recommends certain vaccines at different ages. At birth, the BCG vaccine is given if the baby is at risk of tuberculosis. At 2, 3, and 4 months, the ‘6-1 vaccine’ (diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B) and oral rotavirus vaccine are given, along with Men B and PCV at certain intervals. At 12-13 months, the Hib/Men C, MMR, and PCV vaccines are given, along with Men B. At 3-4 years, the ‘4-in-1 preschool booster’ (diphtheria, tetanus, whooping cough and polio) and MMR vaccines are given. At 12-13 years, the HPV vaccination is given, and at 13-18 years, the ‘3-in-1 teenage booster’ (tetanus, diphtheria and polio) and Men ACWY vaccines are given. Additionally, the flu vaccine is recommended annually for children aged 2-8 years.

It is important to note that the meningitis ACWY vaccine has replaced meningitis C for 13-18 year-olds due to an increased incidence of meningitis W disease in recent years. The ACWY vaccine will also be offered to new students (up to the age of 25 years) at university. GP practices will automatically send letters inviting 17-and 18-year-olds in school year 13 to have the Men ACWY vaccine. Students going to university or college for the first time as freshers, including overseas and mature students up to the age of 25, should contact their GP to have the Men ACWY vaccine, ideally before the start of the academic year.

It is worth noting that the Men C vaccine used to be given at 3 months but has now been discontinued. This is because the success of the Men C vaccination programme means there are almost no cases of Men C disease in babies or young children in the UK any longer. All children will continue to be offered the Hib/Men C vaccine at one year of age, and the Men ACWY vaccine at 14 years of age to provide protection across all age groups.

Management of Gastroschisis in Neonates

Gastroschisis is a condition in which the abdominal contents herniate through the abdominal wall, without the covering of a sac of amniotic membrane and peritoneum. This poses a higher risk to the neonate than exomphalos, which has a covering. The management of gastroschisis involves incubation to maintain body temperature, fluid-resuscitation to prevent dehydration and hypovolaemia, and surgical intervention within a few hours, unless there is evidence of impaired bowel perfusion. Elective surgery is not appropriate for gastroschisis. Restricting fluids would result in organ hypoperfusion and death. Abdominal X-rays are not necessary, and surgical review is obviously appropriate, but surgical intervention is the priority.

When a child experiences nocturnal enuresis, an enuresis alarm is typically the first option if general advice has not been effective. According to NICE guidelines, this is the primary approach. It may be worthwhile to consider a more appealing reward system to motivate the child, as they may not be incentivized if the prize is not deemed valuable. However, it is assumed that the mother can adequately motivate their child, so this may not be the chosen route for the clinic. If the initial intervention is unsuccessful, it is unlikely that repeating it will yield different results. If the enuresis alarm is not effective, pharmacological interventions such as desmopressin, oxybutynin, and unlicensed tolterodine may be considered, with desmopressin being the usual choice.

Nocturnal enuresis, or bedwetting, is when a child involuntarily urinates during the night. Most children achieve continence by the age of 3 or 4, so enuresis is defined as the involuntary discharge of urine in a child aged 5 or older without any underlying medical conditions. Enuresis can be primary, meaning the child has never achieved continence, or secondary, meaning the child has been dry for at least 6 months before.

When managing bedwetting, it’s important to look for any underlying causes or triggers, such as constipation, diabetes mellitus, or recent onset UTIs. General advice includes monitoring fluid intake and encouraging regular toileting patterns, such as emptying the bladder before sleep. Reward systems, like star charts, can also be helpful, but should be given for agreed behavior rather than dry nights.

The first-line treatment for bedwetting is an enuresis alarm, which has a high success rate. These alarms have sensor pads that detect wetness and wake the child up to use the toilet. If short-term control is needed, such as for sleepovers, or if the alarm is ineffective or not acceptable to the family, desmopressin may be prescribed. Overall, managing bedwetting involves identifying any underlying causes and implementing strategies to promote continence.

Regular monitoring of weight and height is recommended every 6 months for patients taking methylphenidate, a stimulant medication. This is important as the drug may cause appetite suppression and growth impairment in children. Additionally, blood pressure and pulse should also be monitored regularly.

In March 2018, NICE released new guidelines for identifying and managing Attention Deficit Hyperactivity Disorder (ADHD). This condition can have a significant impact on a child’s life and can continue into adulthood, making accurate diagnosis and treatment crucial. According to DSM-V, ADHD is characterized by persistent features of inattention and/or hyperactivity/impulsivity, with an element of developmental delay. Children up to the age of 16 must exhibit six of these features, while those aged 17 or over must exhibit five. ADHD has a UK prevalence of 2.4%, with a higher incidence in boys than girls, and there may be a genetic component.

NICE recommends a holistic approach to treating ADHD that is not solely reliant on medication. After presentation, a ten-week observation period should be implemented to determine if symptoms change or resolve. If symptoms persist, referral to secondary care is necessary, typically to a paediatrician with a special interest in behavioural disorders or to the local Child and Adolescent Mental Health Service (CAMHS). A tailored plan of action should be developed, taking into account the patient’s needs and wants, as well as how their condition affects their lives.

Drug therapy should be considered a last resort and is only available to those aged 5 years or older. Parents of children with mild/moderate symptoms can benefit from attending education and training programmes. For those who do not respond or have severe symptoms, pharmacotherapy may be considered. Methylphenidate is the first-line treatment for children and should be given on a six-week trial basis. It is a CNS stimulant that primarily acts as a dopamine/norepinephrine reuptake inhibitor. Side effects include abdominal pain, nausea, and dyspepsia. Weight and height should be monitored every six months in children. If there is an inadequate response, lisdexamfetamine should be considered, followed by dexamfetamine if necessary. In adults, methylphenidate or lisdexamfetamine are the first-line options, with switching between drugs if no benefit is seen after a trial of the other. All of these drugs are potentially cardiotoxic, so a baseline ECG should be performed before starting treatment, and referral to a cardiologist should be made if there is any significant past medical history or family history, or any doubt or ambiguity.

As with most psychiatric conditions, a thorough history and clinical examination are essential, particularly given the overlap of ADHD with many other psychiatric and

To manage a newborn with symptomatic hypoglycaemia, the appropriate course of action is to administer a bolus of dextrose to prevent further neurological symptoms such as seizures, coma or apnoea. Admitting the infant to the neonatal unit is recommended to ensure proper care is provided, but breastfeeding alone is not sufficient to correct the hypoglycaemia quickly enough to prevent potential complications. Keeping the infant on the postnatal ward and encouraging breastfeeding is inappropriate, as this setting is not equipped to manage a potentially severely unwell infant. Repeating the heel prick glucose measurement in one hour is unnecessary, as one measurement is enough to initiate treatment without waiting for a second confirmatory test. Obtaining a venous sample for laboratory glucose testing is also unnecessary, as a heel prick test is accurate enough to confirm the hypoglycaemia and treatment should not be delayed while awaiting laboratory confirmation.

Neonatal Hypoglycaemia: Causes, Symptoms, and Management

Neonatal hypoglycaemia is a common condition in newborn babies, especially in the first 24 hours of life. While there is no agreed definition, a blood glucose level of less than 2.6 mmol/L is often used as a guideline. Transient hypoglycaemia is normal and usually resolves on its own, but persistent or severe hypoglycaemia may be caused by various factors such as preterm birth, maternal diabetes mellitus, IUGR, hypothermia, neonatal sepsis, inborn errors of metabolism, nesidioblastosis, or Beckwith-Wiedemann syndrome.

Symptoms of neonatal hypoglycaemia can be autonomic, such as jitteriness, irritability, tachypnoea, and pallor, or neuroglycopenic, such as poor feeding/sucking, weak cry, drowsiness, hypotonia, and seizures. Other features may include apnoea and hypothermia. Management of neonatal hypoglycaemia depends on the severity of the condition and whether the newborn is symptomatic or not. Asymptomatic babies can be encouraged to feed normally and have their blood glucose monitored, while symptomatic or severely hypoglycaemic babies may need to be admitted to the neonatal unit and receive intravenous infusion of 10% dextrose.

Biliary atresia is diagnosed when a newborn presents with prolonged jaundice, hepatomegaly, splenomegaly, abnormal growth, and cardiac murmurs. Surgery is the preferred treatment, specifically a hepatoportoenterostomy (HPE), also known as Kasai portoenterostomy. This procedure removes the blocked bile ducts and replaces them with a segment of the small intestine, restoring bile flow from the liver to the proximal small bowel. Ursodeoxycholic acid may be given as an adjuvant after surgery to facilitate bile flow and protect the liver. However, it should not be given if the total bilirubin is >256.6 micromol/L (>15 mg/dL). Frequent monitoring is not sufficient, urgent action is required. Liver transplant is not the first-line treatment, but may be considered if HPE is unsuccessful or if there are signs of end-stage liver disease, progressive cholestasis, hepatocellular decompensation, or severe portal hypertension.

Understanding Biliary Atresia in Neonatal Children

Biliary atresia is a condition that affects the extrahepatic biliary system in neonatal children, resulting in an obstruction in the flow of bile. This condition is more common in females than males and occurs in 1 in every 10,000-15,000 live births. There are three types of biliary atresia, with type 3 being the most common. Patients typically present with jaundice, dark urine, pale stools, and abnormal growth.

To diagnose biliary atresia, doctors may perform various tests, including serum bilirubin, liver function tests, serum alpha 1-antitrypsin, sweat chloride test, and ultrasound of the biliary tree and liver. Surgical intervention is the only definitive treatment for biliary atresia, and medical intervention includes antibiotic coverage and bile acid enhancers following surgery.

Complications of biliary atresia include unsuccessful anastomosis formation, progressive liver disease, cirrhosis, and eventual hepatocellular carcinoma. However, the prognosis is good if surgery is successful. In cases where surgery fails, liver transplantation may be required in the first two years of life. Overall, understanding biliary atresia is crucial for early diagnosis and effective management in neonatal children.

Due to the baby’s age of less than 24 hours, there is a high risk of severe hyperbilirubinaemia. It is crucial to urgently measure their serum bilirubin levels within 2 hours, as using a transcutaneous bilirubinometer is not suitable at this stage. While phototherapy can be used to treat jaundice, it is important to first measure the serum bilirubin levels to determine if exchange transfusion is necessary. This information is based on the NICE Guideline CG98 for Jaundice in newborn babies under 28 days.

Jaundice in newborns can occur within the first 24 hours of life and is always considered pathological. The causes of jaundice during this period include rhesus and ABO haemolytic diseases, hereditary spherocytosis, and glucose-6-phosphodehydrogenase deficiency. On the other hand, jaundice in neonates from 2-14 days is common and usually physiological, affecting up to 40% of babies. This type of jaundice is due to a combination of factors such as more red blood cells, fragile red blood cells, and less developed liver function. Breastfed babies are more likely to develop this type of jaundice.

If jaundice persists after 14 days (21 days for premature babies), a prolonged jaundice screen is performed. This includes tests for conjugated and unconjugated bilirubin, direct antiglobulin test, thyroid function tests, full blood count and blood film, urine for MC&S and reducing sugars, and urea and electrolytes. Prolonged jaundice can be caused by biliary atresia, hypothyroidism, galactosaemia, urinary tract infection, breast milk jaundice, prematurity, and congenital infections such as CMV and toxoplasmosis. Breast milk jaundice is more common in breastfed babies and is thought to be due to high concentrations of beta-glucuronidase, which increases the intestinal absorption of unconjugated bilirubin. Prematurity also increases the risk of kernicterus.

If a baby appears nervous and has low muscle tone, it could indicate neonatal hypoglycemia. It is important to check the baby’s blood glucose levels, especially if the mother has been taking labetalol. Additionally, if the mother has used opiates or illegal drugs during pregnancy, the baby may also exhibit symptoms of neonatal abstinence syndrome.

Neonatal Hypoglycaemia: Causes, Symptoms, and Management

Neonatal hypoglycaemia is a common condition in newborn babies, especially in the first 24 hours of life. While there is no agreed definition, a blood glucose level of less than 2.6 mmol/L is often used as a guideline. Transient hypoglycaemia is normal and usually resolves on its own, but persistent or severe hypoglycaemia may be caused by various factors such as preterm birth, maternal diabetes mellitus, IUGR, hypothermia, neonatal sepsis, inborn errors of metabolism, nesidioblastosis, or Beckwith-Wiedemann syndrome.

Symptoms of neonatal hypoglycaemia can be autonomic, such as jitteriness, irritability, tachypnoea, and pallor, or neuroglycopenic, such as poor feeding/sucking, weak cry, drowsiness, hypotonia, and seizures. Other features may include apnoea and hypothermia. Management of neonatal hypoglycaemia depends on the severity of the condition and whether the newborn is symptomatic or not. Asymptomatic babies can be encouraged to feed normally and have their blood glucose monitored, while symptomatic or severely hypoglycaemic babies may need to be admitted to the neonatal unit and receive intravenous infusion of 10% dextrose.

If the neonate is not showing any symptoms and the blood glucose levels are not significantly low, the recommended approach for neonatal hypoglycaemia is to monitor glucose levels and encourage normal feeding. As the mother is diabetic, the neonate is at a higher risk of developing hypoglycaemia. However, administering oral glucose is not necessary at this stage. Admission to the neonatal unit and dextrose infusion would be necessary if the blood glucose levels drop significantly or if the neonate shows symptoms of hypoglycaemia. Intramuscular glucagon would only be considered if the neonate is symptomatic and unable to receive dextrose through IV access. The guidelines do not recommend exclusively bottle-feeding for the next 24 hours.

Neonatal Hypoglycaemia: Causes, Symptoms, and Management

Neonatal hypoglycaemia is a common condition in newborn babies, especially in the first 24 hours of life. While there is no agreed definition, a blood glucose level of less than 2.6 mmol/L is often used as a guideline. Transient hypoglycaemia is normal and usually resolves on its own, but persistent or severe hypoglycaemia may be caused by various factors such as preterm birth, maternal diabetes mellitus, IUGR, hypothermia, neonatal sepsis, inborn errors of metabolism, nesidioblastosis, or Beckwith-Wiedemann syndrome.

Symptoms of neonatal hypoglycaemia can be autonomic, such as jitteriness, irritability, tachypnoea, and pallor, or neuroglycopenic, such as poor feeding/sucking, weak cry, drowsiness, hypotonia, and seizures. Other features may include apnoea and hypothermia. Management of neonatal hypoglycaemia depends on the severity of the condition and whether the newborn is symptomatic or not. Asymptomatic babies can be encouraged to feed normally and have their blood glucose monitored, while symptomatic or severely hypoglycaemic babies may need to be admitted to the neonatal unit and receive intravenous infusion of 10% dextrose.

It is imperative to promptly schedule an evaluation for a child under the age of three who is experiencing a sudden limp.

Causes of Limping in Children

Limping in children can be caused by various factors, which may differ depending on the child’s age. One possible cause is transient synovitis, which has an acute onset and is often accompanied by viral infections. This condition is more common in boys aged 2-12 years. On the other hand, septic arthritis/osteomyelitis may cause a child to feel unwell and have a high fever. Juvenile idiopathic arthritis may cause a painless limp, while trauma can usually be diagnosed through the child’s history. Development dysplasia of the hip is usually detected in neonates and is six times more common in girls. Perthes disease, which is due to avascular necrosis of the femoral head, is more common in children aged 4-8 years. Finally, slipped upper femoral epiphysis may occur in children aged 10-15 years and is characterized by the displacement of the femoral head epiphysis postero-inferiorly. It is important to identify the cause of a child’s limp in order to provide appropriate treatment and prevent further complications.

A postural variation is observed in a benign ejection systolic murmur. Conversely, all other characteristics are indicative of pathological murmurs. The presence of even mild symptoms is concerning, as it suggests that the murmur is not benign.

Innocent murmurs are common in children and are usually harmless. There are different types of innocent murmurs, including ejection murmurs, venous hums, and Still’s murmur. Ejection murmurs are caused by turbulent blood flow at the outflow tract of the heart, while venous hums are due to turbulent blood flow in the great veins returning to the heart. Still’s murmur is a low-pitched sound heard at the lower left sternal edge.

An innocent ejection murmur is characterized by a soft-blowing murmur in the pulmonary area or a short buzzing murmur in the aortic area. It may vary with posture and is localized without radiation. There is no diastolic component, no thrill, and no added sounds such as clicks. The child is usually asymptomatic, and there are no other abnormalities.

Overall, innocent murmurs are not a cause for concern and do not require treatment. However, if a child has symptoms such as chest pain, shortness of breath, or fainting, further evaluation may be necessary to rule out any underlying heart conditions.

Mebendazole is the recommended first-line treatment for threadworm infestations. This particular case presents with typical symptoms of a threadworm infection, which is a common helminth in children. The infection is usually acquired through the ingestion of eggs found in the environment, often from touching soil and then putting hands in the mouth. While the infection is often asymptomatic, it can cause perianal itching, especially at night. Diagnosis is often made empirically, and treatment typically involves hygiene recommendations and mebendazole.

Diethylcarbamazine is an anti-helminthic medication used to treat filarial infections, such as those caused by Wuchereria bancrofti (which can lead to elephantiasis) and Toxocara canis (which can cause visceral larva migrans and retinal granulomas).

Ivermectin is another antiparasitic drug, but it is used to treat Strongyloides stercoralis infections, which can cause symptoms such as diarrhea, abdominal pain, and papulovesicular lesions where the skin has been penetrated by infective larvae.

Metronidazole, on the other hand, is an antibiotic used to treat a variety of bacterial infections, such as gingivitis, pelvic inflammatory disease, syphilis, and bacterial vaginosis. It is not effective in treating threadworms.

Threadworm Infestation in Children

Threadworm infestation, caused by Enterobius vermicularis or pinworms, is a common occurrence among children in the UK. The infestation happens when eggs present in the environment are ingested. In most cases, threadworm infestation is asymptomatic, but some possible symptoms include perianal itching, especially at night, and vulval symptoms in girls. Diagnosis can be made by applying Sellotape to the perianal area and sending it to the laboratory for microscopy to see the eggs. However, most patients are treated empirically, and this approach is supported in the CKS guidelines.

The CKS recommends a combination of anthelmintic with hygiene measures for all members of the household. Mebendazole is the first-line treatment for children over six months old, and a single dose is given unless the infestation persists. It is essential to treat all members of the household to prevent re-infection. Proper hygiene measures, such as washing hands regularly, keeping fingernails short, and washing clothes and bedding at high temperatures, can also help prevent the spread of threadworm infestation.

Juvenile idiopathic arthritis, also known as Still’s disease, is identified by the presence of a distinct salmon-pink rash along with joint pain. While joint pain may also be present in Henoch-Schonlein purpura, the rash in this condition is palpable and purpuric. Meningitis, on the other hand, is characterized by a non-blanching purpuric rash but does not cause joint pain.

Understanding Systemic Onset Juvenile Idiopathic Arthritis

Juvenile idiopathic arthritis (JIA) is a condition that affects individuals under the age of 16 and lasts for more than six weeks. It is also known as juvenile chronic arthritis. Systemic onset JIA, also referred to as Still’s disease, is a type of JIA that presents with several symptoms. These symptoms include pyrexia, a salmon-pink rash, lymphadenopathy, arthritis, uveitis, anorexia, and weight loss.

When investigating systemic onset JIA, doctors may find that the antinuclear antibody (ANA) is positive, especially in oligoarticular JIA. However, the rheumatoid factor is usually negative. It is important to note that systemic onset JIA can be challenging to diagnose, as its symptoms can mimic other conditions.

Understanding Turner’s Syndrome

Turner’s syndrome is a genetic disorder that affects approximately 1 in 2,500 females. It is caused by the absence of one sex chromosome (X) or a deletion of the short arm of one of the X chromosomes. This condition is denoted as 45,XO or 45,X.

The features of Turner’s syndrome include short stature, a shield chest with widely spaced nipples, a webbed neck, a bicuspid aortic valve (15%), coarctation of the aorta (5-10%), primary amenorrhea, cystic hygroma (often diagnosed prenatally), a high-arched palate, a short fourth metacarpal, multiple pigmented naevi, lymphoedema in neonates (especially feet), and elevated gonadotrophin levels. Hypothyroidism is much more common in Turner’s syndrome, and there is also an increased incidence of autoimmune disease (especially autoimmune thyroiditis) and Crohn’s disease.

In summary, Turner’s syndrome is a chromosomal disorder that affects females and can cause a range of physical features and health issues. Early diagnosis and management can help individuals with Turner’s syndrome lead healthy and fulfilling lives.

Understanding the Barlow and Ortolani Manoeuvres for Hip Dislocation Screening

Hip dislocation is a common problem in infants, and early detection is crucial for successful treatment. Two screening tests commonly used are the Barlow and Ortolani manoeuvres. The Barlow manoeuvre involves adducting the hip while applying pressure on the knee, while the Ortolani manoeuvre flexes the hips and knees to 90 degrees, with pressure applied to the greater trochanters and thumbs to abduct the legs. A positive test confirms hip dislocation, and further investigation is necessary if risk factors are present, such as breech delivery or a family history of hip problems. However, a negative test does not exclude all hip problems, and parents should seek medical advice if they notice any asymmetry or walking difficulties in their child.

The appropriate initial treatment for meningitis in patients over 3 months of age is intravenous administration of a 3rd generation cephalosporin, specifically ceftriaxone. This is important to consider in patients with non-specific symptoms but concerning observations and examination findings. Intramuscular or oral benzylpenicillin is not the correct choice for initial empirical therapy, as it is reserved for use in the community before transfer to the hospital. Intravenous cephalexin is also not appropriate, as it is a first-generation cephalosporin and is administered orally rather than intravenously.

Investigation and Management of Meningitis in Children

Meningitis is a serious condition that can affect children. When investigating meningitis, it is important to note any contraindications to lumbar puncture, such as signs of raised intracranial pressure, focal neurological signs, papilloedema, significant bulging of the fontanelle, disseminated intravascular coagulation, or signs of cerebral herniation. For patients with meningococcal septicaemia, a lumbar puncture is contraindicated, and blood cultures and PCR for meningococcal should be obtained instead.

The management of meningitis in children involves administering antibiotics, such as IV amoxicillin (or ampicillin) and IV cefotaxime for children under three months, and IV cefotaxime (or ceftriaxone) for children over three months. Steroids should be considered if the lumbar puncture reveals certain findings, such as purulent cerebrospinal fluid, a high white blood cell count, or bacteria on Gram stain. Fluids should be administered to treat shock, and cerebral monitoring should be conducted, including mechanical ventilation if necessary.

It is also important to notify public health authorities and administer antibiotic prophylaxis to contacts. Ciprofloxacin is now preferred over rifampicin for this purpose. Overall, prompt and appropriate management of meningitis in children is crucial for ensuring the best possible outcomes.

Parents should be informed that if their child experiences a febrile convulsion lasting more than 5 minutes, they should call for an ambulance. While some children may have recurrent febrile convulsions, simple ones typically last up to 15 minutes and result in complete recovery within an hour. In these cases, parents can manage their child at home with clear guidance on when to seek medical help, including the use of buccal midazolam or rectal diazepam. However, if a febrile convulsion lasts longer than 5 minutes, an ambulance should be called. If there is a subsequent convulsion lasting less than 5 minutes with a recovery time of 30-60 minutes, the child may be able to stay at home. However, if a febrile convulsion lasts longer than 10 or 15 minutes, an ambulance should have already been called after the initial 5 minutes.

Febrile convulsions are seizures caused by fever in children aged 6 months to 5 years. They typically last less than 5 minutes and are most commonly tonic-clonic. There are three types: simple, complex, and febrile status epilepticus. Children who have had a first seizure or any features of a complex seizure should be admitted to pediatrics. Regular antipyretics do not reduce the chance of a febrile seizure occurring. The overall risk of further febrile convulsion is 1 in 3, with risk factors including age of onset, fever duration, family history, and link to epilepsy. Children without risk factors have a 2.5% risk of developing epilepsy, while those with all three features have a much higher risk.

The patient’s symptoms, including cough, conjunctivitis, fever, and a rash with Koplik spots, suggest a diagnosis of measles. Measles is characterized by these symptoms, as well as a maculopapular rash that starts behind the ears. The presence of Koplik spots is a key indicator of measles. It is worth noting that some groups, such as the Roma community, have lower rates of vaccination against measles, mumps, and rubella.

Epstein Barr virus is an incorrect answer. While it can cause fever and sore throat, it is less likely to present with a rash and Koplik spots. Instead, cervical lymphadenopathy is a more prominent feature. Palatal petechiae may be visible early on.

Rubella is also an incorrect answer. While it can cause a rash on the face, there is no presence of Koplik spots. Additionally, fever tends to be less severe. Post-auricular and suboccipital lymphadenopathy may be present.

Scarlet fever is another incorrect answer. The rash associated with scarlet fever typically starts on the abdomen and spreads to the back and limbs. Sore throat is a prominent symptom, and there may be tonsillar exudate. Cough is not typically present, and a strawberry tongue may be visible.

Measles: A Highly Infectious Viral Disease

Measles is a viral disease caused by an RNA paramyxovirus. It is one of the most infectious known viruses and is spread through aerosol transmission. The disease has an incubation period of 10-14 days and is infective from the prodromal phase until four days after the rash starts. Measles is now rare in developed countries due to immunization programs, but outbreaks can occur when vaccination rates drop, such as during the MMR controversy of the early 2000s.

The disease is characterized by a prodromal phase, which includes irritability, conjunctivitis, fever, and Koplik spots. The latter typically develop before the rash and are white spots on the buccal mucosa. The rash starts behind the ears and then spreads to the whole body, becoming a discrete maculopapular rash that may become blotchy and confluent. Desquamation may occur after a week, typically sparing the palms and soles. Diarrhea occurs in around 10% of patients.

Measles is mainly managed through supportive care, and admission may be considered in immunosuppressed or pregnant patients. The disease is notifiable, and public health should be informed. Complications of measles include otitis media, pneumonia (the most common cause of death), encephalitis (typically occurring 1-2 weeks following the onset of the illness), subacute sclerosing panencephalitis (very rare, may present 5-10 years following the illness), febrile convulsions, keratoconjunctivitis, corneal ulceration, diarrhea, increased incidence of appendicitis, and myocarditis.

If an unimmunized child comes into contact with measles, MMR should be offered within 72 hours. Vaccine-induced measles antibody develops more rapidly than that following natural infection.

The most likely cause of this patient’s dyspnoea at rest, combined with being generally unwell and the time of year, is croup. Croup is commonly caused by the parainfluenza virus. Bordetella pertussis, Parvovirus B19, and Respiratory syncytial virus are unlikely causes as they present with different symptoms and are associated with different conditions.

Understanding Croup: A Respiratory Infection in Infants and Toddlers

Croup is a type of upper respiratory tract infection that commonly affects infants and toddlers. It is characterized by a barking cough, fever, and coryzal symptoms, and is caused by a combination of laryngeal oedema and secretions. Parainfluenza viruses are the most common cause of croup. The condition typically peaks between 6 months and 3 years of age, and is more prevalent during the autumn season.

The severity of croup can be graded based on the presence of symptoms such as stridor, cough, and respiratory distress. Mild cases may only have occasional barking cough and no audible stridor at rest, while severe cases may have frequent barking cough, prominent inspiratory stridor at rest, and marked sternal wall retractions. Children with moderate or severe croup, those under 6 months of age, or those with known upper airway abnormalities should be admitted to the hospital.

Diagnosis of croup is usually made based on clinical presentation, but a chest x-ray may show subglottic narrowing, commonly referred to as the steeple sign. Treatment for croup typically involves a single dose of oral dexamethasone or prednisolone, regardless of severity. In emergency situations, high-flow oxygen and nebulized adrenaline may be necessary.

Understanding croup is important for parents and healthcare providers alike, as prompt recognition and treatment can help prevent complications and improve outcomes for affected children.

When a slipped upper femoral epiphysis (SCFE) occurs, it is crucial to seek immediate medical attention as there is a risk of avascular necrosis of the femoral head. Referral to paediatric orthopaedics is necessary, and the child should not bear weight and should be given pain relief to ensure comfort. The most effective treatment for SCFE is internal fixation surgery, which prevents the slip from worsening. The Ponseti method, which involves a series of manipulations and casts over several weeks, is typically used to treat clubfoot.

Slipped Capital Femoral Epiphysis: A Rare Hip Condition in Children

Slipped capital femoral epiphysis, also known as slipped upper femoral epiphysis, is a rare hip condition that primarily affects children between the ages of 10 and 15. It is more commonly seen in obese boys. This condition is characterized by the displacement of the femoral head epiphysis postero-inferiorly, which may present acutely following trauma or with chronic, persistent symptoms.

The most common symptoms of slipped capital femoral epiphysis include hip, groin, medial thigh, or knee pain and loss of internal rotation of the leg in flexion. In some cases, a bilateral slip may occur. Diagnostic imaging, such as AP and lateral (typically frog-leg) views, can confirm the diagnosis.

The management of slipped capital femoral epiphysis typically involves internal fixation, which involves placing a single cannulated screw in the center of the epiphysis. However, if left untreated, this condition can lead to complications such as osteoarthritis, avascular necrosis of the femoral head, chondrolysis, and leg length discrepancy.

In summary, slipped capital femoral epiphysis is a rare hip condition that primarily affects children, especially obese boys. It is characterized by the displacement of the femoral head epiphysis postero-inferiorly and can present with various symptoms. Early diagnosis and management are crucial to prevent complications.

Croup is a viral illness that affects young children, causing a sudden-onset barking cough and upper airway inflammation. Mild cases can be treated with a single dose of oral dexamethasone, while moderate to severe cases require admission and nebulised adrenaline. This child has mild croup and should be given a single dose of oral dexamethasone before being discharged home with clear instructions on when to seek further medical attention. If the child develops any signs of respiratory distress, they should be taken to the Emergency Department immediately.

Physiological Jaundice in Infants

Physiological jaundice is a common occurrence in newborns, affecting around 90% of infants. It typically appears after the first two to three days of life and is caused by an increase in the breakdown of red blood cells and the relative immaturity of the liver. This type of jaundice is not usually a cause for concern and will often resolve on its own within a few weeks. However, if anemia is present, it may indicate a more serious underlying condition, such as hemolytic anemia. It is important for healthcare providers to monitor newborns for signs of jaundice and to investigate any potential underlying causes.

Understanding Intraventricular Haemorrhage

Intraventricular haemorrhage is a rare condition that involves bleeding into the ventricular system of the brain. While it is typically associated with severe head injuries in adults, it can occur spontaneously in premature neonates. In fact, the majority of cases occur within the first 72 hours after birth. The exact cause of this condition is not well understood, but it is believed to be a result of birth trauma and cellular hypoxia in the delicate neonatal central nervous system.

Treatment for intraventricular haemorrhage is largely supportive, as therapies such as intraventricular thrombolysis and prophylactic cerebrospinal fluid drainage have not been shown to be effective. However, if hydrocephalus and rising intracranial pressure occur, shunting may be necessary. It is important for healthcare professionals to be aware of this condition and its potential complications in order to provide appropriate care for affected patients.

Marfan syndrome is a connective tissue disease with cardiovascular complications such as aortic root dilation and aneurysm. Diagnosis is based on clinical features, family history, and genetic testing. The Ghent criteria are commonly used, with emphasis on cardiac manifestations. Echocardiographic surveillance is required, and prophylactic medications are used to reduce the chance of aortic root dilation. Aortic regurgitation may require surgery. Marfan syndrome is associated with non-cardiac features, and the clinical criteria can be found on the American National Marfan Foundation website.

It is not recommended to give antidiarrhoeal medications to children under 5 years old who have diarrhoea and vomiting caused by gastroenteritis. This is because these medications do not provide any benefits and can cause side effects such as ileus, drowsiness, and nausea. It is also important to discourage the consumption of fruit juices and carbonated drinks, especially for those who are at risk of dehydration. Antibiotics are not routinely recommended for children with gastroenteritis as they do not effectively treat symptoms or prevent complications. The patient in question does not require antibiotic treatment. IV fluid therapy is not necessary as the patient is not clinically dehydrated and can be rehydrated with oral rehydration solution (ORS) and increased daily fluid intake. However, IV fluid therapy may be necessary if the patient shows signs of clinical dehydration or if they persistently vomit the ORS solution.

Understanding Diarrhoea in Children

Diarrhoea is a common condition in children that can be caused by various factors. One of the most common causes is gastroenteritis, which is often accompanied by fever and vomiting for the first two days. The main risk associated with this condition is severe dehydration, which can be life-threatening if left untreated. The most common cause of gastroenteritis is rotavirus, and the diarrhoea may last up to a week. The treatment for this condition is rehydration.

Chronic diarrhoea is another type of diarrhoea that can affect infants and toddlers. In the developed world, the most common cause of chronic diarrhoea in infants is cow’s’ milk intolerance. Toddler diarrhoea, on the other hand, is characterized by stools that vary in consistency and often contain undigested food. Other causes of chronic diarrhoea in children include coeliac disease and post-gastroenteritis lactose intolerance.

Bronchiolitis can be more severe in individuals with congenital heart disease, particularly those with a ventricular septal defect. Fragile X is not associated with increased severity, but Down’s syndrome has been linked to worse episodes. Formula milk feeding is a risk factor for bronchiolitis, but does not affect the severity of the disease once contracted. While bronchiolitis is most common in infants aged 3-6 months, this age range is not indicative of a more severe episode. However, infants younger than 12 weeks are at higher risk. Being born at term is not a risk factor, but premature birth is associated with more severe episodes.

Bronchiolitis is a condition where the bronchioles become inflamed, and it is most commonly caused by respiratory syncytial virus (RSV). This virus is responsible for 75-80% of cases, with other causes including mycoplasma and adenoviruses. Bronchiolitis is most prevalent in infants under one year old, with 90% of cases occurring in those aged 1-9 months. The condition is more serious in premature babies, those with congenital heart disease or cystic fibrosis. Symptoms include coryzal symptoms, dry cough, increasing breathlessness, and wheezing. Hospital admission is often necessary due to feeding difficulties associated with increasing dyspnoea.

Immediate referral is recommended if the child has apnoea, looks seriously unwell, has severe respiratory distress, central cyanosis, or persistent oxygen saturation of less than 92% when breathing air. Clinicians should consider referral if the child has a respiratory rate of over 60 breaths/minute, difficulty with breastfeeding or inadequate oral fluid intake, or clinical dehydration. Immunofluorescence of nasopharyngeal secretions may show RSV, and management is largely supportive. Humidified oxygen is given via a head box if oxygen saturations are persistently low, and nasogastric feeding may be necessary if children cannot take enough fluid/feed by mouth. Suction may also be used for excessive upper airway secretions. NICE released guidelines on bronchiolitis in 2015 for more information.

The table summarizes developmental milestones for social behavior, feeding, dressing, and play. Milestones include smiling at 6 weeks, using a spoon and cup at 12-15 months, and playing with other children at 4 years.

The probable diagnosis based on the examination findings is pulmonary ductus arteriosus (PDA), which is characterized by a ‘machinery-like’ murmur. The recommended treatment for this condition is the administration of indomethacin or ibuprofen, which inhibits prostaglandin production and promotes duct closure. The use of prostaglandin E1 is not appropriate in this case, as it would keep the duct open. Referral for routine or urgent surgery is also not necessary, as no other congenital heart defects were found on the echocardiogram. Monitoring and repeating echocardiograms alone are not sufficient and medical intervention is required for closure of the duct.

Patent ductus arteriosus is a type of congenital heart defect that is typically classified as ‘acyanotic’. However, if left untreated, it can eventually lead to late cyanosis in the lower extremities, which is known as differential cyanosis. This condition is caused by a connection between the pulmonary trunk and descending aorta that fails to close with the first breaths due to increased pulmonary flow that enhances prostaglandins clearance. Patent ductus arteriosus is more common in premature babies, those born at high altitude, or those whose mothers had rubella infection during the first trimester of pregnancy.

The features of patent ductus arteriosus include a left subclavicular thrill, a continuous ‘machinery’ murmur, a large volume, bounding, collapsing pulse, a wide pulse pressure, and a heaving apex beat. To manage this condition, indomethacin or ibuprofen is given to the neonate, which inhibits prostaglandin synthesis and closes the connection in the majority of cases. If patent ductus arteriosus is associated with another congenital heart defect that is amenable to surgery, then prostaglandin E1 is useful to keep the duct open until after surgical repair.

Tetralogy of Fallot is a common congenital heart disease that affects around 3-6 out of every 10,000 births. It is characterized by four heart abnormalities that can cause symptoms such as cyanosis, difficulty with feeding, failure to thrive, and Tet spells. Diagnosis is typically made through echocardiography, and surgical correction is usually performed within the first two years of life.

Cyanotic heart disease can be divided into two groups: those that present in the first week of life and those that present after the first week. Examples of conditions that present in the first week include total pulmonary atresia, tricuspid atresia, and transposition of the great arteries. Examples of conditions that can present after the first week include tetralogy of Fallot, total anomalous pulmonary venous drainage, and tricuspid regurgitation with right-to-left shunt via atrial septal defect.

Transposition of the great arteries is a cyanotic congenital heart condition where the aorta arises from the right ventricle and the pulmonary arteries from the left ventricle. It typically presents with central cyanosis within the first day or two of life and is managed with intravenous prostaglandin E1 and balloon atrial septostomy.

Total pulmonary atresia is a congenital heart abnormality where the pulmonary valve fails to develop, resulting in disrupted blood flow from the right ventricle to the pulmonary trunk. It can occur with or without a ventricular septal defect and is associated with tetralogy of Fallot.

Ventricular septal defect is a congenital heart defect located in the interventricular septum that allows mixing of blood between the two sides of the heart. Symptoms depend on the size of the defect and can range from asymptomatic to signs of heart failure.

Patent ductus arteriosus is the failure of closure of the fetal connection between the descending aorta and pulmonary artery. It is not a cyanotic congenital heart defect and can be treated with intravenous indomethacin, cardiac catheterization, or ligation. Symptoms may include decreased exercise tolerance, pulmonary congestion, a cardiac murmur, or heart failure.